CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 95 enrolled
Drug / intervention
B. breve strain +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04677738
NCT04677738N/ACompleted
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults

Morinaga Milk Industry Co., LTD·interventional·Posted Dec 21, 2020·Updated Oct 20, 2025

In Brief

A clinical study evaluating B. breve strain and Placebo for Obesity and Overweight and Obesity. Completed, enrolled 95 participants across 1 site.

Detailed Summary

Overweight has become a critical issue in North America and the market value of weight loss products is expected to rise as the population becomes more health-conscious and aware of the risks associated with excess body weight. This randomized, placebo-controlled, clinical trial investigates the effect of Bifidobacterium breve supplementation with exercise intervention on fat loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Overweight and Obesity
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 21, 2020
Enrollment StartAug 20, 2020
Primary CompletionJan 5, 2024
TodayJul 1, 2026
Enrollment to primary: 3.4 yearsPosted 5.5 years ago

Interventions

B. breve straindietary

Probiotic capsule. Participants will be instructed to take 2 capsules of placebo for 4 weeks during the run-in period. On day 1 participants will be instructed to take 2 capsules of B. breve strain in the morning before breakfast for 12 weeks.

Placebodietary

Placebo capsule. Participants will be instructed to take 2 capsules of placebo for 4 weeks during the run-in period. On day 1 participants will be instructed to take 2 capsules of placebo in the morning before breakfast for 12 weeks.